Senolytic Drugs Show Promise Against Bone Loss Caused by Chemotherapy
A new mouse study shows that senolytic drugs targeting senescent cells can partially mitigate the bone loss and marrow fat ...
A new mouse study shows that senolytic drugs targeting senescent cells can partially mitigate the bone loss and marrow fat ...
A new letter in the Journal of Translational Medicine argues that a senolytic vaccine study showed real therapeutic benefit in ...
A new study in BMC Cancer shows that the protease ADAM17 is upregulated in aggressive canine mammary carcinomas and promotes ...
A new study in rats and cardiac cells shows that the natural naphthoquinone shikonin protects the heart from doxorubicin chemotherapy ...
A proof-of-concept study shows proton magnetic resonance spectroscopy can detect the chemotherapy drug doxorubicin inside liver tissue after transarterial chemoembolization, ...
Researchers have developed a thermoresponsive injectable gel that co-delivers doxorubicin with reserpine to block P-glycoprotein and CD44, overcoming multidrug resistance ...
A phase 2 trial found that brentuximab vedotin and nivolumab added to limited chemotherapy produced a 92 percent complete response ...
Injecting healthy mitochondria from stem cells into aged mice restored cardiac function by reactivating a blocked mitochondrial waste-disposal pathway controlled ...
A retrospective study of 66 cats treated with the anthracycline chemotherapy drug epirubicin found that side effects were mostly mild ...
A retrospective Australian cohort study found that a more than twelvefold increase in doxorubicin concentration during conventional transarterial chemoembolization produced ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine